We are almost there ...
Gland Pharma has a battle on its hands
The Hyderabad-based contract manufacturer has seen its big European bet sour. Can its new CEO move mountains?
20 November, 2024•12 min
0
20 November, 2024•12 min
0
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
SUBSCRIBE
Already have an account? Sign In
More in Business
Business
Patanjali to buy Magma General Insurance from Adar Poonawalla
The deal, valued at Rs 4,500 crore, will mark a major diversification for the packaged goods company associated with Baba Ramdev.
You may also like
Internet
Why quick delivery of medicines will be difficult to scale
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.
Business
How Glenmark convinced its investors to back its high-risk R&D strategy
While earlier attempts were unsuccessful, with Glenmark running into huge losses, there seems to be growing consensus that the drugmaker’s R&D strategy makes it a different company. Perhaps even a valuable one.
Internet
Why is Swiggy catching flak for its latest quick-delivery promise?
The food and grocery delivery company’s idea of providing prescription drugs in 10 minutes is facing resistance from traditional pharma players.
